Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 25:15:103-109.
doi: 10.2147/IJWH.S334719. eCollection 2023.

Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives

Lorena Lorefice  1 , Maurizio Nicola D'Alterio  2 , Davide Firinu  3 , Giuseppe Fenu  4 , Eleonora Cocco  1
Affiliations
Review

Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives

Lorena Lorefice et al. Int J Womens Health. .

Abstract

Given the aging population, with a peak age-specific prevalence that is shifting beyond the age of 50, several women currently living with MS are very close to menopause. Menopause is usually characterized by several specific symptoms with adverse impacts on different aspects of a woman's quality of life, such as fatigue, and cognitive, mood and bladder disorders, which overlap with symptoms of MS. Generally, after this biological transition, women with MS appear to be subject to less inflammatory activity. However, several studies have reported an increase of disability accumulation after menopause, suggesting that it is a turning point to a more progressive phase of the disease. This may be attributable to the hormonal and immunological changes associated with menopause, with several effects on neuroinflammation and neurodegeneration increasing due to the immunosenescence of aging. This review summarizes the hormonal and immunological changes associated with menopause, detailing the effects on MS symptoms, outcomes, and the aging process. Furthermore, possible interventions to improve patients' quality of life are evaluated. In fact, it is increasingly necessary to improve the global management of MS women, as well as their lives, at this multifaceted turning point.

Keywords: aging; best practice; hormone therapy; menopause; multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work. Eleonora Cocco reports grants, personal fees, and non-financial support from Biogen and Merck; personal fees and non-financial support from Novartis; grants from Roche; and personal fees from Genzyme, outside the submitted work.

References

    1. Filippi M, Bar-Or A, Piehl F., et al. Multiple sclerosis. Nat Rev Dis Primers. 2018;4(1):43. doi:10.1038/s41572-018-0041-4 - DOI - PubMed
    1. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2:777–780. doi:10.1038/ni0901-777 - DOI - PubMed
    1. Koch-Henriksen N, Thygesen LC, Stenager E, et al. Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women. Neurology. 2018;90(22):e1954–63. doi:10.1212/WNL.0000000000005612 - DOI - PubMed
    1. Prosperini L, Lucchini M, Ruggieri S, et al. Shift of multiple sclerosis onset towards older age. J Neurol Neurosurg Psychiatry. 2022;jnnp-2022–329049. - PubMed
    1. Kalincik T, Vivek V, Jokubaitis V, et al. Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain. 2013;136:3609–3617. doi:10.1093/brain/awt281 - DOI - PubMed